[HK]和铂医药-B:自愿公告 - 和铂医药获得中国监管部门对新药临床试验申请的批准以开展HBM9161针对慢性炎性脱髓鞘性多发性神经根神经病(CIDP)的二期临床试验- CFi.CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
Related Keywords